156 related articles for article (PubMed ID: 16493674)
1. Myelin protein zero: mutations in the cytoplasmic domain interfere with its cellular trafficking.
Konde V; Eichberg J
J Neurosci Res; 2006 May; 83(6):957-64. PubMed ID: 16493674
[TBL] [Abstract][Full Text] [Related]
2. Altered trafficking and adhesion function of MPZ mutations and phenotypes of Charcot-Marie-Tooth disease 1B.
Matsuyama W; Nakagawa M; Takashima H; Osame M
Acta Neuropathol; 2002 May; 103(5):501-8. PubMed ID: 11935267
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic clustering in MPZ mutations.
Shy ME; Jáni A; Krajewski K; Grandis M; Lewis RA; Li J; Shy RR; Balsamo J; Lilien J; Garbern JY; Kamholz J
Brain; 2004 Feb; 127(Pt 2):371-84. PubMed ID: 14711881
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination.
Xu W; Shy M; Kamholz J; Elferink L; Xu G; Lilien J; Balsamo J
J Cell Biol; 2001 Oct; 155(3):439-46. PubMed ID: 11673479
[TBL] [Abstract][Full Text] [Related]
5. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
[TBL] [Abstract][Full Text] [Related]
6. Normal expression of myelin protein zero with frame-shift mutation correlates with mild phenotype.
Steck AJ; Erne B; Pareyson D; Sghirlanzoni A; Taroni F; Schaeren-Wiemers N
J Peripher Nerv Syst; 2006 Mar; 11(1):61-6. PubMed ID: 16519783
[TBL] [Abstract][Full Text] [Related]
7. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration.
Li J; Bai Y; Ianakova E; Grandis M; Uchwat F; Trostinskaia A; Krajewski KM; Garbern J; Kupsky WJ; Shy ME
J Comp Neurol; 2006 Sep; 498(2):252-65. PubMed ID: 16856127
[TBL] [Abstract][Full Text] [Related]
8. Clinical and cellular characterization of two novel MPZ mutations, p.I135M and p.Q187PfsX63.
Lin KP; Soong BW; Chang MH; Chen WT; Lin JL; Lee WJ; Lee YC
Clin Neurol Neurosurg; 2012 Feb; 114(2):124-9. PubMed ID: 22018721
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation.
Eggers SD; Keswani SC; Melli G; Cornblath DR
Muscle Nerve; 2004 Jun; 29(6):867-9. PubMed ID: 15170620
[TBL] [Abstract][Full Text] [Related]
10. Screening of the myelin protein zero gene in patients with Charcot-Marie-Tooth disease.
Nowakowski A; Kochański A
Acta Biochim Pol; 2004; 51(1):273-80. PubMed ID: 15094849
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation, Thr65Ala, in the MPZ gene in a patient with Charcot-Marie-Tooth type 1B disease with focally folded myelin.
Kochanski A; Drac H; Kabzińska D; Hausmanowa-Petrusewicz I
Neuromuscul Disord; 2004 Mar; 14(3):229-32. PubMed ID: 15036333
[TBL] [Abstract][Full Text] [Related]
12. Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B.
Sabet A; Li J; Ghandour K; Pu Q; Wu X; Kamholz J; Shy ME; Cambi F
Neurology; 2006 Oct; 67(7):1141-6. PubMed ID: 17030746
[TBL] [Abstract][Full Text] [Related]
13. Peripheral neuropathies caused by mutations in the myelin protein zero.
Shy ME
J Neurol Sci; 2006 Mar; 242(1-2):55-66. PubMed ID: 16414078
[TBL] [Abstract][Full Text] [Related]
14. Early onset Charcot-Marie-Tooth type 1B disease caused by a novel Leu190fs mutation in the myelin protein zero gene.
Kochański A; Kabzińska D; Drac H; Ryniewicz B; Rowińska-Marcińska K; Hausmanowa-Petrusewicz I
Eur J Paediatr Neurol; 2004; 8(4):221-4. PubMed ID: 15261887
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the carboxypeptidase D cytoplasmic domain: Implications in intracellular trafficking.
Kalinina E; Varlamov O; Fricker LD
J Cell Biochem; 2002; 85(1):101-11. PubMed ID: 11891854
[TBL] [Abstract][Full Text] [Related]
16. Myelin protein zero gene mutations in Taiwanese patients with Charcot-Marie-Tooth disease type 1.
Lee YC; Soong BW; Lin KP; Lee HY; Wu ZA; Kao KP
J Neurol Sci; 2004 Apr; 219(1-2):95-100. PubMed ID: 15050444
[TBL] [Abstract][Full Text] [Related]
17. A new MPZ mutation associated with a mild CMT1 phenotype presenting with recurrent nerve compression.
Magot A; Latour P; Mussini JM; Mourtada R; Guiheneuc P; Pereon Y
Muscle Nerve; 2008 Aug; 38(2):1055-9. PubMed ID: 18663734
[TBL] [Abstract][Full Text] [Related]
18. Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations.
Grandis M; Vigo T; Passalacqua M; Jain M; Scazzola S; La Padula V; Brucal M; Benvenuto F; Nobbio L; Cadoni A; Mancardi GL; Kamholz J; Shy ME; Schenone A
Hum Mol Genet; 2008 Jul; 17(13):1877-89. PubMed ID: 18337304
[TBL] [Abstract][Full Text] [Related]
19. Marked phenotypic variation in a family with a new myelin protein zero mutation.
Szabo A; Züchner S; Siska E; Mechler F; Molnar MJ
Neuromuscul Disord; 2005 Nov; 15(11):760-3. PubMed ID: 16198109
[TBL] [Abstract][Full Text] [Related]
20. Charcot-Marie-Tooth disease type 1B: marked phenotypic variation of the Ser78Leu mutation in five Italian families.
Mazzeo A; Muglia M; Rodolico C; Toscano A; Patitucci A; Quattrone A; Messina C; Vita G
Acta Neurol Scand; 2008 Nov; 118(5):328-32. PubMed ID: 18422810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
